These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3140032)

  • 1. The costs of crime and the benefits of drug abuse treatment: a cost-benefit analysis using TOPS data.
    Harwood HJ; Hubbard RL; Collins JJ; Rachal JV
    NIDA Res Monogr; 1988; 86():209-35. PubMed ID: 3140032
    [No Abstract]   [Full Text] [Related]  

  • 2. The criminal justice client in drug abuse treatment.
    Hubbard RL; Collins JJ; Rachal JV; Cavanaugh ER
    NIDA Res Monogr; 1988; 86():57-80. PubMed ID: 3140035
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines and challenges for estimating the economic costs and benefits of adolescent substance abuse treatments.
    Zavala SK; French MT; Henderson CE; Alberga L; Rowe C; Liddle HA
    J Subst Abuse Treat; 2005 Oct; 29(3):191-205. PubMed ID: 16183468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compulsory treatment: a review of findings.
    Leukefeld CG; Tims FM
    NIDA Res Monogr; 1988; 86():236-51. PubMed ID: 3140033
    [No Abstract]   [Full Text] [Related]  

  • 5. Economic benefits of substance abuse treatment: findings from Cuyahoga County, Ohio.
    Koenig L; Siegel JM; Harwood H; Gilani J; Chen YJ; Leahy P; Stephens R
    J Subst Abuse Treat; 2005; 28 Suppl 1():S41-50. PubMed ID: 15797638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reductions in criminal convictions after addiction treatment: 5-year follow-up.
    Gossop M; Trakada K; Stewart D; Witton J
    Drug Alcohol Depend; 2005 Sep; 79(3):295-302. PubMed ID: 16102373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM; Raskin IE; Blacklow B
    Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS).
    Godfrey C; Stewart D; Gossop M
    Addiction; 2004 Jun; 99(6):697-707. PubMed ID: 15139868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment alternatives to street crime.
    Cook LF; Weinman BA
    NIDA Res Monogr; 1988; 86():99-105. PubMed ID: 3140038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National study of drug abuse treatment finds benefits include less drug use, fewer crimes.
    Hosp Community Psychiatry; 1989 Dec; 40(12):1309-10. PubMed ID: 2512243
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of alcohol and drug treatment programs.
    Caldwel JR
    J Fla Med Assoc; 1993 Jun; 80(6):385-6. PubMed ID: 8340771
    [No Abstract]   [Full Text] [Related]  

  • 13. A cost-effectiveness model for evaluating health care programs: application to drug abuse treatment.
    Goldschmidt PG
    Inquiry; 1976 Mar; 13(1):29-47. PubMed ID: 130347
    [No Abstract]   [Full Text] [Related]  

  • 14. Substance abuse, treatment, and the courts. Alcohol and drug abuse contributing factor in 80% of U.S. crimes.
    J Psychosoc Nurs Ment Health Serv; 1997 Jul; 35(7):8-9. PubMed ID: 9243416
    [No Abstract]   [Full Text] [Related]  

  • 15. The nature and status of drug abuse treatment.
    Nurco DN; Kinlock TW; Hanlon TE
    Md Med J; 1994 Jan; 43(1):51-7. PubMed ID: 8183085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The costs of pursuing accreditation for methadone treatment sites: results from a national study.
    Zarkin GA; Dunlap LJ; Homsi G
    Eval Rev; 2006 Apr; 30(2):119-38. PubMed ID: 16492995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socioeconomic analysis of addictions treatment.
    Langenbucher JW
    Public Health Rep; 1996; 111(2):135-7. PubMed ID: 8606910
    [No Abstract]   [Full Text] [Related]  

  • 19. Legal status and long-term outcomes for addicts in the DARP followup project.
    Simpson DD; Friend HJ
    NIDA Res Monogr; 1988; 86():81-98. PubMed ID: 3140037
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of drug abuse treatment: relevant issues and alternative longitudinal modeling approaches.
    Hser YI; Anglin MD
    NIDA Res Monogr; 1991; 113():67-93. PubMed ID: 1762644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.